I am delighted to provide an update on Initiator Pharma’s progress and achievements during the start of 2024, building upon previous year’s successes where we achieved multiple important milestones across our development pipeline. We have continued to advance our goal of progressing novel drug candidates toward the market in a cost and time effective way, for the benefit of both patients in need of improved medical therapies and for our shareholders, while also strengthening our position in the market.